RELX:NYSERELX PLC PLC Analysis
Data as of 2026-05-24 - not real-time
$33.01
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
RELX trades at $33.01, sitting just above the computed support level of $31.02 and below both the 20‑day (≈$34.31) and 50‑day (≈$34.27) simple moving averages, indicating limited short‑term upside. The RSI of 42 and a bearish MACD histogram reinforce a neutral‑to‑slightly bearish technical backdrop, with the price also facing resistance near $36.90. Fundamentally, the company posts a solid operating margin of 31% and a striking ROE of 70%, but its balance sheet is heavily leveraged (debt‑to‑equity ≈304) and cash reserves are modest relative to debt. The forward PE of 15.2 and a current PE of 21.9 are well below the industry average of 29.7, suggesting a relative value edge, yet the DCF‑derived fair value of $12.70 is far beneath the market price, highlighting a potential overvaluation signal. Dividend sustainability appears reasonable with a 2.79% yield and a 57% payout ratio supported by strong operating cash flow. Overall, the stock sits in a low‑beta (≈0.48) environment with 30% 30‑day volatility, offering modest defensive characteristics but heightened financial risk due to leverage. The confluence of bearish technical cues, strong margins, high debt, and divergent valuation signals suggests a cautious stance, especially for longer horizons.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below short‑term SMAs and near support
- Bearish MACD and neutral RSI
- Stable volume with limited upside to resistance
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong operating margins and ROE
- High debt‑to‑equity ratio limiting financial flexibility
- Valuation gap between market price and DCF fair value
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Overvaluation relative to intrinsic DCF estimate
- Elevated leverage and modest cash cushion
- Technical indicators pointing to continued downside pressure
Key Metrics & Analysis
Financial Health
Revenue Growth1.20%
Profit Margin21.53%
P/E Ratio21.9
ROE70.51%
ROA12.49%
Debt/Equity304.06
P/B Ratio76.3
Op. Cash Flow$2.8B
Free Cash Flow$2.2B
Industry P/E29.7
Technical Analysis
TrendNeutral
RSI42.1
Support$31.02
Resistance$36.90
MA 20$34.31
MA 50$34.27
MA 200$39.76
MACDBearish
VolumeStable
Fear & Greed Index91.61
Valuation
Fair Value$12.70
Target Price$52.45
Upside/Downside58.89%
GradeOvervalued
TypeValue
Dividend Yield2.79%
Risk Assessment
Beta0.48
Volatility30.90%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.